DNA polymerase extension assay
    3.
    发明授权
    DNA polymerase extension assay 失效
    DNA聚合酶延伸测定

    公开(公告)号:US6100028A

    公开(公告)日:2000-08-08

    申请号:US973139

    申请日:1998-07-31

    IPC分类号: C12Q1/68 C12P19/34

    CPC分类号: C12Q1/6806

    摘要: The present invention provides rapid accurate sensitive assays specific for the detection of at least one a single stranded oligonucleotide produced by the action of an enzyme on a substrate. The assays are useful to detect the presence in a sample of an enzyme which acts on an oligonucleotide substrate to generate a single stranded oligonucleotide product and to detect inhibitors of such an enzyme.

    摘要翻译: PCT No.PCT / US96 / 08330 Sec。 371日期:1998年7月31日 102(e)1998年7月31日PCT PCT 1996年6月3日PCT公布。 出版物WO96 / 40994 日期1996年12月19日本发明提供了对通过酶在基质上的作用产生的至少一种单链寡核苷酸的检测特异性的快速精确的敏感性测定。 测定法可用于检测在寡核苷酸底物上作用于酶的样品中的存在以产生单链寡核苷酸产物并检测这种酶的抑制剂。

    Capped synthetic RNA, analogs, and aptamers
    4.
    发明授权
    Capped synthetic RNA, analogs, and aptamers 失效
    封盖的合成RNA,类似物和适体

    公开(公告)号:US06369208B1

    公开(公告)日:2002-04-09

    申请号:US08973137

    申请日:1998-03-30

    IPC分类号: C07H2102

    摘要: A method is provided for making synthetic capped RNAs. These compounds serve as substrates for the virally encoded endonuclease associated with influenza virus. We are able to assay for this unique and specific viral activity of cleavage of a capped RNA in vitro. Therefore, screening of inhibitors of this activity is possible. In addition, short non-extendible (due to their length or because of the modification of the 3′-end of the oligo, i.e. 3′-dA) RNAs are potent inhibitors of the cleavage of capped RNAs by influenza endonuclease. Finally, these compounds may be used to investigate viral and cellular mechanisms of transcription/translation or mRNA maturation.

    摘要翻译: 提供了制备合成上限RNA的方法。 这些化合物用作与流感病毒相关的病毒编码的内切核酸酶的底物。 我们能够测定这种在体外切割加盖RNA的独特且特异的病毒活性。 因此,可以筛选该活性的抑制剂。 此外,短的不可延伸的(由于其长度或由于寡核苷酸的3'末端的修饰,即3'-dA)RNA是流感内切核酸酶切割加帽RNA的有效抑制剂。 最后,这些化合物可用于研究转录/翻译或mRNA成熟的病毒和细胞机制。

    DNA polymerase extension assay for influenza virus endonuclease
    5.
    发明授权
    DNA polymerase extension assay for influenza virus endonuclease 失效
    流感病毒内切核酸酶的DNA聚合酶延伸测定

    公开(公告)号:US5660989A

    公开(公告)日:1997-08-26

    申请号:US487759

    申请日:1995-06-07

    IPC分类号: C12Q1/68 C12Q1/70

    CPC分类号: C12Q1/701 C12Q1/6846

    摘要: An assay for the influenza virus endonuclease has been developed which involves DNA polymerase-catalyzed extension of the viral endonuclease cleavage product using labeled nucleotides and a DNA template containing a 3' region complementary to the product joined to a 5' region consisting of repeated residues. The DNA polymerase coupled assay does not involve gel electrophoretic separation and is amenable to high volume screening of potential inhibitors. Another key feature of the assay is that it is sensitive enough to detect 200 attomoles of product.

    摘要翻译: 已经开发了用于流感病毒核酸内切酶的测定法,其涉及使用标记的核苷酸对病毒核酸内切酶切割产物进行DNA聚合酶催化的延伸,并且包含与连接到由重复残基组成的5'区域的产物互补的3'区域的DNA模板。 DNA聚合酶偶联测定不涉及凝胶电泳分离,并且适于对潜在的抑制剂进行高体积筛选。 该测定的另一个关键特征是足够敏感以检测200个产品的阿托莫尔。

    Nucleoside Aryl Phosphoramidates for the Treatment of RNA-Dependent RNA Viral Infection
    9.
    发明申请
    Nucleoside Aryl Phosphoramidates for the Treatment of RNA-Dependent RNA Viral Infection 有权
    用于治疗RNA依赖性RNA病毒感染的核苷芳基磷酰胺化物

    公开(公告)号:US20100234316A1

    公开(公告)日:2010-09-16

    申请号:US12223940

    申请日:2007-02-12

    CPC分类号: C07H19/06

    摘要: The present invention provides nucleoside aryl phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as precursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside aryl phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside aryl phosphoramidates of the present invention.

    摘要翻译: 本发明提供结构式(I)的核苷芳基氨基磷酸酯,其是RNA依赖性RNA病毒聚合酶抑制剂的前体。 这些化合物是RNA依赖性RNA病毒复制抑制剂的前体,可用于治疗RNA依赖性RNA病毒感染。 它们特别可用作丙型肝炎病毒(HCV)NS5B聚合酶抑制剂的前体,作为HCV复制抑制剂的前体和/或治疗丙型肝炎感染。 本发明还描述了单独或与其它对RNA依赖性RNA病毒感染,特别是HCV感染有活性的试剂组合的含有这种核苷芳基氨基磷酸酯的药物组合物。 还公开了本发明的核苷芳基氨基磷酸酯抑制RNA依赖性RNA聚合酶,抑制RNA依赖性RNA病毒复制和/或治疗RNA依赖性RNA病毒感染的方法。